🇺🇸 FDA
Patent

US 6689367

Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences

expired A61KA61K2039/525A61K39/00

Quick answer

US patent 6689367 (Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K2039/525, A61K39/00